Medindia
Medindia LOGIN REGISTER
Advertisement

AbbVie to Present at the Goldman Sachs 38th Annual Global Healthcare Conference

Wednesday, May 24, 2017 Drug News
Advertisement
NORTH CHICAGO, Ill., May 24, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 38th Annual Global Healthcare Conference on Tuesday, June 13, 2017. Bill Chase, executive vice president and chief financial officer, will present at 10 a.m. Central time.
Advertisement

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.    
Advertisement

About AbbVieAbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience.  In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook or LinkedIn.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/abbvie-to-present-at-the-goldman-sachs-38th-annual-global-healthcare-conference-300462854.html

SOURCE AbbVie

Sponsored Post and Backlink Submission


Latest Press Release on Drug News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close